Ruth Chapman

960 total citations
24 papers, 659 citations indexed

About

Ruth Chapman is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Ruth Chapman has authored 24 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Microbiology. Recurrent topics in Ruth Chapman's work include Pneumonia and Respiratory Infections (9 papers), Respiratory viral infections research (7 papers) and HIV/AIDS Research and Interventions (5 papers). Ruth Chapman is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Respiratory viral infections research (7 papers) and HIV/AIDS Research and Interventions (5 papers). Ruth Chapman collaborates with scholars based in United Kingdom, United States and Uganda. Ruth Chapman's co-authors include T. Déirdre Hollingsworth, Christophe Fraser, William P. Hanage, Frank de Wolf, Mark Jit, Matt Wasserman, Desmond Dillon-Murphy, Mary Ramsay, Ross Harris and Shreeya Patel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Hepatology and International Journal of Epidemiology.

In The Last Decade

Ruth Chapman

22 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Chapman United Kingdom 12 354 231 151 119 96 24 659
M Arneborn Sweden 15 324 0.9× 270 1.2× 99 0.7× 114 1.0× 98 1.0× 26 790
Rachel N. Bronzan United States 15 238 0.7× 253 1.1× 88 0.6× 104 0.9× 299 3.1× 26 940
Mary Allen United States 19 220 0.6× 312 1.4× 350 2.3× 69 0.6× 130 1.4× 57 1.1k
Stuart Skinner Canada 13 271 0.8× 278 1.2× 51 0.3× 29 0.2× 82 0.9× 32 579
David C. Wright United States 10 374 1.1× 269 1.2× 448 3.0× 105 0.9× 63 0.7× 15 985
P P Mortimer Nepal 13 436 1.2× 333 1.4× 384 2.5× 79 0.7× 165 1.7× 20 870
Maria Xiridou Netherlands 16 616 1.7× 345 1.5× 267 1.8× 23 0.2× 37 0.4× 39 885
Jessica Ingersoll United States 16 353 1.0× 491 2.1× 194 1.3× 41 0.3× 54 0.6× 34 988
Omu Anzala Kenya 15 265 0.7× 287 1.2× 93 0.6× 24 0.2× 59 0.6× 43 633
P. G. McIntyre United Kingdom 19 550 1.6× 178 0.8× 194 1.3× 45 0.4× 106 1.1× 30 824

Countries citing papers authored by Ruth Chapman

Since Specialization
Citations

This map shows the geographic impact of Ruth Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Chapman more than expected).

Fields of papers citing papers by Ruth Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Chapman. The network helps show where Ruth Chapman may publish in the future.

Co-authorship network of co-authors of Ruth Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Chapman. A scholar is included among the top collaborators of Ruth Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Chapman. Ruth Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rozenbaum, Mark H., Liping Huang, Alejandro Cané, et al.. (2024). Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13. Journal of Medical Economics. 27(1). 644–652. 6 indexed citations
3.
Rozenbaum, Mark H., Liping Huang, Johnna Perdrizet, et al.. (2024). Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants. Vaccine. 42(3). 573–582. 10 indexed citations
4.
5.
Perdrizet, Johnna, et al.. (2023). Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population. Human Vaccines & Immunotherapeutics. 19(2). 2257426–2257426. 25 indexed citations
6.
Rozenbaum, Mark H., Liping Huang, Johnna Perdrizet, et al.. (2023). 1737. Cost-Effectiveness Analysis of Catch-Up Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
7.
Chapman, Ruth, et al.. (2020). Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Vaccine. 38(45). 7138–7145. 32 indexed citations
8.
Lapidot, Rotem, Ruth Chapman, Kelly Sutton, et al.. (2020). 1404. Twenty-year impact of Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease in US children less than 5 years of age. Open Forum Infectious Diseases. 7(Supplement_1). S709–S710. 1 indexed citations
9.
Browne, Chantelle, N. Muszbek, Ruth Chapman, et al.. (2016). Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin. International Journal of Antimicrobial Agents. 47(5). 357–361. 10 indexed citations
10.
Marsh, Kevin, Ruth Chapman, Rebecca F. Baggaley, Nathalie Largeron, & Xavier Bresse. (2014). Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination?. Vaccine. 32(30). 3732–3739. 18 indexed citations
11.
Shafer, Leigh Anne, Rebecca N. Nsubuga, Ruth Chapman, et al.. (2014). The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study. Sexually Transmitted Infections. 90(5). 423–429. 10 indexed citations
12.
13.
Muszbek, N., Ruth Chapman, Chantelle Browne, et al.. (2013). Using Daptomycin in Hospitalised Patients with cSSTI Caused by <b><i>Staphylococcus aureus </i></b>Has an Impact on Costs. Chemotherapy. 59(6). 427–434. 1 indexed citations
14.
Choi, Yoon Hong, Ruth Chapman, Nigel Gay, & Mark Jit. (2012). Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: Quantification using a multi-type mathematical model. Vaccine. 30(23). 3383–3388. 19 indexed citations
15.
Chapman, Ruth, Kate Soldan, & Mark Jit. (2011). Modelling borderline and mild dysplasia associated with HPV 6 and 11 infection. Vaccine. 29(16). 2881–2886. 3 indexed citations
16.
Shafer, Leigh Anne, Rebecca N. Nsubuga, Richard G. White, et al.. (2011). Antiretroviral therapy and sexual behavior in Uganda: a cohort study. AIDS. 25(5). 671–678. 26 indexed citations
17.
Desai, Sarika, Ruth Chapman, Mark Jit, et al.. (2011). Prevalence of Human Papillomavirus Antibodies in Males and Females in England. Sexually Transmitted Diseases. 38(7). 622–629. 41 indexed citations
18.
Shafer, Leigh Anne, Richard G. White, Rebecca N. Nsubuga, et al.. (2010). The role of the natural epidemic dynamics and migration in explaining the course of the HIV epidemic in rural Uganda: a modelling study. International Journal of Epidemiology. 40(2). 397–404.
19.
Baggaley, Rebecca F., Jamie T. Griffin, Ruth Chapman, et al.. (2009). Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load. AIDS. 23(8). 1005–1013. 14 indexed citations
20.
Fraser, Christophe, T. Déirdre Hollingsworth, Ruth Chapman, Frank de Wolf, & William P. Hanage. (2007). Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis. Proceedings of the National Academy of Sciences. 104(44). 17441–17446. 303 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Arneborn Breakdown of academic impact, for papers by Rachel N. Bronzan Breakdown of academic impact, for papers by Mary Allen Breakdown of academic impact, for papers by Stuart Skinner Breakdown of academic impact, for papers by David C. Wright Breakdown of academic impact, for papers by P P Mortimer Breakdown of academic impact, for papers by Maria Xiridou Breakdown of academic impact, for papers by Jessica Ingersoll Breakdown of academic impact, for papers by Omu Anzala Breakdown of academic impact, for papers by P. G. McIntyre
Rankless by CCL
2026